Search

everythinglearnresearchcommunity

for

Search:↓

An imbalance between certain immune cells is linked to a chronic skin condition and may be influenced by obesity, smoking, and autoimmune issues.

Non-immune factors play a significant role in alopecia areata.

The analysis aims to identify the most effective and safest treatments for alopecia areata.

UK medical students lack dermatology education, liver biopsy patients with risk factors show more fibrosis, and certain fungi resist drugs due to melanin; genetics may influence female hair loss.

Immune cells help regulate hair growth, and better understanding this can improve hair loss treatments.

Special and immunohistochemical stains are not routinely needed for diagnosing hair disorders.

New treatments for skin conditions show promise, especially Coacillium® for hair growth in young people with alopecia areata.

Different causes of beard hair loss have various treatments, including medications, lifestyle changes, and procedures to stimulate hair growth.

Patients with rheumatoid arthritis using tofacitinib had more serious side effects than those with alopecia areata.

The review provided information on various treatments to stop hair thinning and increase hair density in people with common genetic hair loss.

Certain genes are linked to the quality of cashmere in goats.

Understanding how Regulatory T Cells work could help create treatments for certain skin diseases and cancers.

Hair loss in Androgenetic Alopecia is caused by genetics, aging, and lifestyle, leading to hair follicle shrinkage and related health risks.

Adults and adolescents with severe alopecia areata are willing to take significant health risks for a better chance of hair regrowth.

Alopecia areata severity and treatment response are linked to specific cytokine levels.

Finasteride, Dutasteride, and Minoxidil are effective for hair growth, while new treatments like laser therapy and PRP show promise with few side effects.

New treatments for alopecia areata show promise, but more research is needed to confirm their effectiveness.

A new drug, abrocitinib, helped a child with severe hair loss regrow hair.

Tofacitinib can help hair grow back in alopecia patients but hair loss might return if the dose is lowered.

Human skin xenografting could improve our understanding of skin development, renewal, and healing.

The Hedgehog Signaling Pathway is important for skin and hair development and skin cancer treatment, but more research is needed to understand it fully.

New treatments for ichthyosis, like protein replacement and gene therapy, show promise and may become standard care.

Tofacitinib helps regrow hair in severe alopecia patients, but more research is needed.

New regenerative treatments for hair loss show promise but need more research for confirmation.

Alopecia areata causes a significant economic burden in Japan, mainly due to productivity loss.

Phototherapy helps some patients with alopecia areata regrow hair, especially those with hair at treatment start and less severe forms of the condition.

Ruxolitinib effectively and safely regrows hair in alopecia patients.

The new "whisker follicle microinjection assay" can test how different biomolecules affect hair growth and color.

Gene therapy shows promise for healing chronic wounds but needs more research to overcome challenges.

Baricitinib is effective and safe for long-term use in severe alopecia areata, improving hair regrowth and quality of life with few side effects.